The group’s principle activity is to commercializing novel and proprietary ADMET products for drug discovery and development customers. The group also provides better knowledge to researchers regarding drug candidate compounds. The group’s products include B-clear(R), Accurate(TM), and Accupro(TM). The group operates from United States.
